NO961404D0 - 4-indolylpiperazinyl-derivater - Google Patents

4-indolylpiperazinyl-derivater

Info

Publication number
NO961404D0
NO961404D0 NO961404A NO961404A NO961404D0 NO 961404 D0 NO961404 D0 NO 961404D0 NO 961404 A NO961404 A NO 961404A NO 961404 A NO961404 A NO 961404A NO 961404 D0 NO961404 D0 NO 961404D0
Authority
NO
Norway
Prior art keywords
indolylpiperazinyl
derivatives
indolylpiperazinyl derivatives
Prior art date
Application number
NO961404A
Other languages
English (en)
Other versions
NO961404L (no
Inventor
John Patrick Yardley
III Horace FLETCHER
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO961404D0 publication Critical patent/NO961404D0/no
Publication of NO961404L publication Critical patent/NO961404L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO961404A 1995-04-10 1996-04-09 4-indolylpiperazinyl-derivater NO961404L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/419,333 US5519025A (en) 1995-04-10 1995-04-10 4-indolylpiperazinyl derivatives

Publications (2)

Publication Number Publication Date
NO961404D0 true NO961404D0 (no) 1996-04-09
NO961404L NO961404L (no) 1996-10-11

Family

ID=23661806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961404A NO961404L (no) 1995-04-10 1996-04-09 4-indolylpiperazinyl-derivater

Country Status (14)

Country Link
US (1) US5519025A (no)
EP (1) EP0737677A1 (no)
JP (1) JPH08283262A (no)
KR (1) KR960037677A (no)
AU (1) AU5052296A (no)
BR (1) BR9601295A (no)
CA (1) CA2173693A1 (no)
CZ (1) CZ102896A3 (no)
IL (1) IL117858A0 (no)
MX (1) MX9601326A (no)
NO (1) NO961404L (no)
NZ (1) NZ286340A (no)
SK (1) SK45196A3 (no)
ZA (1) ZA962821B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756283A1 (fr) * 1996-11-27 1998-05-29 Pf Medicament Amines aromatiques d'arylpiperazines, leur preparation et leurs applications comme medicaments
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
DE69819266T2 (de) 1997-09-02 2004-07-29 Duphar International Research B.V. Piperidin- und Piperazin Derivate als 5-HT1-Rezeptor-Agonisten
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
CA2390524A1 (en) 1999-11-12 2001-05-17 John Patrick Yardley Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity
US6831084B1 (en) 1999-11-12 2004-12-14 Wyeth Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity
US6696450B2 (en) * 2001-04-04 2004-02-24 Wyeth Serotonergic agents with long-acting in vivo effects
US7067518B2 (en) * 2002-09-05 2006-06-27 Wyeth Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646048A (en) * 1970-02-02 1972-02-29 American Cyanamid Co N-(tert-aminoalkyl)-2-indenecarboxamides
US3641029A (en) * 1970-02-02 1972-02-08 American Cyanamid Co Substituted benzoxazolecarboxamides and benzothiazolecarboxamides
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
NZ231631A (en) * 1988-12-08 1992-07-28 Duphar Int Res Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
IL94151A (en) * 1989-04-22 1995-08-31 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
AU5052296A (en) 1996-10-24
US5519025A (en) 1996-05-21
EP0737677A1 (en) 1996-10-16
NO961404L (no) 1996-10-11
JPH08283262A (ja) 1996-10-29
IL117858A0 (en) 1996-08-04
ZA962821B (en) 1997-10-09
CZ102896A3 (en) 1996-10-16
NZ286340A (en) 1997-06-24
CA2173693A1 (en) 1996-10-11
MX9601326A (es) 1997-04-30
KR960037677A (ko) 1996-11-19
SK45196A3 (en) 1997-04-09
BR9601295A (pt) 1998-01-13

Similar Documents

Publication Publication Date Title
DE69522717D1 (de) Chinazolinderivate
DE69611361D1 (de) Chinazolin-derivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE59605821D1 (de) l/4-SCALLABSORBER
DE69610698D1 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
NO964667D0 (no) Purin-6-on-derivater
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
ATE240307T1 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
NO961404D0 (no) 4-indolylpiperazinyl-derivater
NO960353D0 (no) 4-aminobenzoylguanidinderivater
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
DK0843675T3 (da) Aza-anthracyclinonderivater
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
NO960392D0 (no) 4-merkaptobenzoylguanidinderivater
DE69620514D1 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate
SE9504432D0 (sv) Ma 3005
NO952571D0 (no) 360 ter
SE9501893D0 (sv) Grepp 1